Fund profile
Tickers
DLHAX, DLHCX, DLRHX, DLHIX
Fund manager
Total assets
$739.28 mm
Liabilities
$7.59 mm
Net assets
$731.69 mm
Number of holdings
98.00
98 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 64.46 mm | 120.00 k shares | 8.81 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 61.72 mm | 75.00 k shares | 8.44 | Common equity | Long | USA |
AMGN AMGEN Inc. | 53.75 mm | 200.00 k shares | 7.35 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 38.32 mm | 76.00 k shares | 5.24 | Common equity | Long | USA |
ABBV Abbvie Inc | 33.77 mm | 226.56 k shares | 4.62 | Common equity | Long | USA |
MRK Merck & Co Inc | 30.37 mm | 295.00 k shares | 4.15 | Common equity | Long | USA |
ELV Elevance Health Inc | 27.43 mm | 63.00 k shares | 3.75 | Common equity | Long | USA |
ROG Rogers Corp. | 21.89 mm | 80.00 k shares | 2.99 | Common equity | Long | Switzerland |
Chugai Pharmaceutical Co Ltd
|
21.66 mm | 700.00 k shares | 2.96 | Common equity | Long | Japan |
BSX Boston Scientific Corp. | 20.06 mm | 380.00 k shares | 2.74 | Common equity | Long | USA |
PFE Pfizer Inc. | 20.05 mm | 604.60 k shares | 2.74 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 18.07 mm | 80.00 k shares | 2.47 | Common equity | Long | USA |
AZN Astrazeneca plc | 17.78 mm | 131.24 k shares | 2.43 | Common equity | Long | UK |
SGEN Seagen Inc. | 16.97 mm | 80.00 k shares | 2.32 | Common equity | Long | USA |
SAN Banco Santander S.A. | 16.63 mm | 155.00 k shares | 2.27 | Common equity | Long | France |
GILD Gilead Sciences, Inc. | 14.61 mm | 195.00 k shares | 2.00 | Common equity | Long | USA |
ILMN Illumina Inc | 13.73 mm | 100.00 k shares | 1.88 | Common equity | Long | USA |
JNJ Johnson & Johnson | 11.96 mm | 76.77 k shares | 1.63 | Common equity | Long | USA |
VTRS Viatris Inc | 11.54 mm | 1.17 mm shares | 1.58 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 11.23 mm | 760.00 k shares | 1.53 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 10.97 mm | 124.00 k shares | 1.50 | Common equity | Long | USA |
BIIB Biogen Inc | 10.28 mm | 40.00 k shares | 1.41 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 9.56 mm | 85.00 k shares | 1.31 | Common equity | Long | USA |
ZBH Zimmer Biomet Holdings Inc | 8.98 mm | 80.00 k shares | 1.23 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 8.86 mm | 170.00 k shares | 1.21 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 8.79 mm | 230.00 k shares | 1.20 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 8.69 mm | 25.00 k shares | 1.19 | Common equity | Long | USA |
ALKS Alkermes plc | 8.40 mm | 300.00 k shares | 1.15 | Common equity | Long | Ireland |
MorphoSys AG
|
8.19 mm | 300.00 k shares | 1.12 | Common equity | Long | Germany |
ALNY Alnylam Pharmaceuticals Inc | 7.26 mm | 41.00 k shares | 0.99 | Common equity | Long | USA |
CVS CVS Health Corp | 6.98 mm | 100.00 k shares | 0.95 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 6.80 mm | 379.10 k shares | 0.93 | Common equity | Long | USA |
PRGO Perrigo Company plc | 6.71 mm | 210.00 k shares | 0.92 | Common equity | Long | Ireland |
EXAS Exact Sciences Corp. | 6.23 mm | 91.35 k shares | 0.85 | Common equity | Long | USA |
UCB SA
|
6.23 mm | 76.00 k shares | 0.85 | Common equity | Long | Belgium |
QURE uniQure N.V. | 4.74 mm | 706.17 k shares | 0.65 | Common equity | Long | Netherlands |
INCY Incyte Corp. | 4.62 mm | 80.00 k shares | 0.63 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 4.16 mm | 28.50 k shares | 0.57 | Common equity | Long | USA |
SYK Stryker Corp. | 4.10 mm | 15.00 k shares | 0.56 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 3.95 mm | 338.18 k shares | 0.54 | Common equity | Long | USA |
KVUE Kenvue Inc | 3.75 mm | 186.60 k shares | 0.51 | Common equity | Long | USA |
SOHU Sohu.com Ltd. | 3.68 mm | 390.72 k shares | 0.50 | Common equity | Long | China |
DGX Quest Diagnostics, Inc. | 3.66 mm | 30.00 k shares | 0.50 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 3.65 mm | 330.10 k shares | 0.50 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 3.33 mm | 160.00 k shares | 0.46 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 2.88 mm | 250.00 k shares | 0.39 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 2.67 mm | 150.00 k shares | 0.36 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 2.61 mm | 60.00 k shares | 0.36 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 2.61 mm | 180.00 k shares | 0.36 | Common equity | Long | USA |
XNCR Xencor Inc | 2.60 mm | 129.19 k shares | 0.36 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 2.50 mm | 70.00 k shares | 0.34 | Common equity | Long | USA |
RGNX Regenxbio Inc | 2.45 mm | 149.00 k shares | 0.34 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 2.24 mm | 230.00 k shares | 0.31 | Common equity | Long | USA |
MGNX Macrogenics Inc | 1.96 mm | 420.00 k shares | 0.27 | Common equity | Long | USA |
BNTX BioNTech SE | 1.96 mm | 18.00 k shares | 0.27 | Common equity | Long | Germany |
CHRS Coherus Biosciences Inc | 1.86 mm | 498.60 k shares | 0.25 | Common equity | Long | USA |
MRNA Moderna Inc | 1.86 mm | 18.00 k shares | 0.25 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 1.80 mm | 208.78 k shares | 0.25 | Common equity | Long | Cayman Islands |
RIGL Rigel Pharmaceuticals | 1.73 mm | 1.60 mm shares | 0.24 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 1.68 mm | 93.73 k shares | 0.23 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 1.58 mm | 13.00 k shares | 0.22 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 1.35 mm | 110.00 k shares | 0.18 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 1.19 mm | 58.00 k shares | 0.16 | Common equity | Long | USA |
PRQR ProQR Therapeutics N.V | 806.00 k | 620.00 k shares | 0.11 | Common equity | Long | Netherlands |
FNMA Federal National Mortgage Association Fannie Mae | 804.70 k | 1.30 mm shares | 0.11 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 802.00 k | 50.00 k shares | 0.11 | Common equity | Long | USA |
CGEN Compugen Ltd | 793.24 k | 852.94 k shares | 0.11 | Common equity | Long | Israel |
NTLA Intellia Therapeutics Inc | 632.40 k | 20.00 k shares | 0.09 | Common equity | Long | USA |
FMCC Federal Home Loan Mortgage Corp | 621.60 k | 1.05 mm shares | 0.08 | Common equity | Long | USA |
BVN Compania de Minas Buenaventura S.A. | 565.33 k | 66.35 k shares | 0.08 | Common equity | Long | Peru |
OGN Organon & Co. | 512.12 k | 29.50 k shares | 0.07 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc | 509.20 k | 380.00 k shares | 0.07 | Common equity | Long | USA |
ICPT Intercept Pharmaceuticals, Inc. | 500.58 k | 27.00 k shares | 0.07 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 471.24 k | 81.96 k shares | 0.06 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 465.29 k | 146.78 k shares | 0.06 | Common equity | Long | USA |
CLLS Cellectis | 358.46 k | 226.88 k shares | 0.05 | Common equity | Long | France |
SGMO Sangamo Therapeutics Inc | 239.92 k | 400.00 k shares | 0.03 | Common equity | Long | USA |
MEIP MEI Pharma Inc | 210.30 k | 30.00 k shares | 0.03 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals Inc | 210.00 k | 70.00 k shares | 0.03 | Common equity | Long | USA |
NXTC Nextcure Inc | 193.50 k | 150.00 k shares | 0.03 | Common equity | Long | USA |
MRSN Mersana Therapeutics Inc | 190.50 k | 150.00 k shares | 0.03 | Common equity | Long | USA |
AMRN Amarin Corp | 174.80 k | 190.00 k shares | 0.02 | Common equity | Long | Ireland |
PBYI Puma Biotechnology Inc | 161.10 k | 61.26 k shares | 0.02 | Common equity | Long | USA |
NKTR Nektar Therapeutics | 152.70 k | 256.39 k shares | 0.02 | Common equity | Long | USA |
Euroapi SA
|
109.67 k | 8.70 k shares | 0.01 | Common equity | Long | France |
ZIMV ZimVie Inc | 75.28 k | 8.00 k shares | 0.01 | Common equity | Long | USA |
LABP Landos Biopharma Inc | 56.96 k | 14.72 k shares | 0.01 | Common equity | Long | USA |
XOMA XOMA Corp | 48.84 k | 3.47 k shares | 0.01 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 44.18 k | 5.70 k shares | 0.01 | Common equity | Long | USA |
FBIO Fortress Biotech Inc | 29.03 k | 100.00 k shares | 0.00 | Common equity | Long | USA |
Contra Surface Oncolog
|
26.95 k | 350.00 k shares | 0.00 | Common equity | Long | USA |
SIOX Sio Gene Therapies Inc. | 24.90 k | 64.17 k shares | 0.00 | Common equity | Long | USA |
MBIO Mustang Bio Inc | 16.40 k | 8.00 k shares | 0.00 | Common equity | Long | USA |
InnoCare Pharma Ltd
|
12.92 k | 17.00 k shares | 0.00 | Common equity | Long | China |
GLMD Galmed Pharmaceuticals Ltd | 12.65 k | 20.40 k shares | 0.00 | Common equity | Long | Israel |
ATNXQ Athenex, Inc. | 53.20 | 3.50 k shares | 0.00 | Common equity | Long | USA |
Proteostasis Theapeutics
|
0 | 750.00 k shares | 0.00 | Common equity | Long | USA |
AMBIT BIOSCIENCES CORP CVR
|
0 | 76.50 k shares | 0.00 | Common equity | Long | USA |